Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Immunospecific NMR contrast agents
1986
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Metal–organic framework composites
2014 Standout
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
2005
Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts
1993
Monocyte and macrophage heterogeneity
2005 Standout
114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-Phe-octreotide
2000
Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas
1988
Drug penetration in solid tumours
2006 Standout
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
2000
Imaging in the era of molecular oncology
2008 StandoutNature
Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins
1987
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
The neurobiology of zinc in health and disease
2005 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Thrombocytopenic Purpura Associated with Brucellosis: Report of 2 Cases and Literature Review
2000
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
1993
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Brucellosis
2005 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Reevaluation of the Impact of a Stringent Low-Iodine Diet on Ablation Rates in Radioiodine Treatment of Thyroid Carcinoma
2001
The importance of selenium to human health
2000 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The immune system in atherosclerosis
2011 Standout
Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice
1991
The immune response in atherosclerosis: a double-edged sword
2006 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
1997 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody
1999 StandoutNobel
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
2004
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Targeting the vulnerable plaque: The evolving role of nuclear imaging
2005
Neurobiology of Zinc and Zinc-Containing Neurons
1989
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
1996 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Amphotericin B: 30 Years of Clinical Experience
1990
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Immunomodulation of Atherosclerosis
2004
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
1994
Current Developments in Cancer Vaccines and Cellular Immunotherapy
2003
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity
1986
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model.
1995
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
1994 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Overview of transition metal and lanthanide complexes as diagnostic tools
1999
Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo
2001
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
1986
Monoclonal antibody-based therapies of leukemia and lymphoma
1992
Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome
1999
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.
1988
Immunohistochemical localization and molecular characteristics of three monoclonal antibody‐defined epitopes detectable on carcinoembryonic antigen (CEA)
1985
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal
2014
Optimizing drug delivery to brain tumors
1987
CD4 cells can be more efficient at tumor rejection than CD8 cells
2007
The Chemistry of Neutron Capture Therapy
1998 Standout
Identification and Characterization of the Immunodominant Rat HER-2/neu MHC Class I Epitope Presented by Spontaneous Mammary Tumors from HER-2/neu-Transgenic Mice
2003
Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease
2000
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
The kidneys in paroxysmal nocturnal hemoglobinuria
1981
New Compounds: Organoboron Derivatives of Tetracyclines I: Synthesis of Carboxamido Derivative of Tetracycline with Perhydro-2-phenyl-l,3,6,2-dioxazaborocine
1977
Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
2002
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation
2004
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Rational approaches to human cancer immunotherapy
2003
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells
1992
Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
1993
Works of Samuel E. Halpern being referenced
Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models.
1983
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo
1999
Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
1988
Pharmacokinetics of an indium-labeled IgG monoclonal antibody over a prolonged period
1995
Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies.
1986
A Re-evaluation of131I Thyroid Tlptakes
1972
Stability studies and tumor uptake of a technetium-tetracycline complex.
1974
In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models.
1985
An Unusual Case of Brucellosis
1968
Use of a Hyperbaric Solution for Administration of Intrathecal Amphotericin B
1974
99m Tc-penicillamine-acetazolamide complex, a new renal scanning agent.
1972
The advantages and limits of indium-111 labeling of antibodies experimental studies and clinical applications
1986
In Vitro and In Vivo Tumor Models for Studies of Distribution of Radiolabelled Monoclonal Antibodies and Fragments
1986
Localization of zinc in the thymic reticulum of mice by electron-probe microanalysis
1984
Urinary Iron Excretion Studies in Paroxysmal Nocturnal Hemoglobinuria
1971
Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.
1984
Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.
1990
Tumor size: effect on monoclonal antibody uptake in tumor models.
1986
Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope
2002
Toxicities associated with monoclonal antibody infusions in cancer patients.
1988
99m TPAC, a new renal scanning agent. II. Evaluation in humans.
1972
Detection of metastatic thyroid carcinoma after the administration of a therapeutic dose of 131-Iodine
1978
Hyberbaric cisternography: experience in humans.
1973
Loculation as a contraindication intracavitary 32P-chromic phosphate therapy.
1975
Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model.
1984